Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000831388 | SCV000973135 | benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001510159 | SCV001717122 | benign | Congenital disorder of glycosylation, type IIq | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000831388 | SCV005284210 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003928301 | SCV004741635 | benign | COG2-related disorder | 2019-07-16 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |